NYSE:BCSFBain Capital Specialty Finance Stock Price, Forecast & News

Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BCSF stock has decreased by 33.5% and is now trading at $11.20. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Bain Capital Specialty Finance.

Bain Capital Specialty Finance is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Bain Capital Specialty Finance.

Bain Capital Specialty Finance Inc (NYSE:BCSF) issued its quarterly earnings results on Monday, May, 4th. The company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.41 by $0.03. The company had revenue of $51.50 million for the quarter, compared to analysts' expectations of $54.41 million. Bain Capital Specialty Finance had a negative net margin of 21.80% and a positive return on equity of 8.72%. View Bain Capital Specialty Finance's earnings history.

Bain Capital Specialty Finance announced a quarterly dividend on Monday, May 4th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.41 per share on Thursday, July 30th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 14.64%. The ex-dividend date of this dividend is Monday, June 29th. View Bain Capital Specialty Finance's dividend history.

5 analysts have issued 1 year price targets for Bain Capital Specialty Finance's shares. Their forecasts range from $7.50 to $19.50. On average, they expect Bain Capital Specialty Finance's share price to reach $12.20 in the next year. This suggests a possible upside of 8.9% from the stock's current price. View analysts' price targets for Bain Capital Specialty Finance.

News headlines about BCSF stock have trended very negative recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Bain Capital Specialty Finance earned a media sentiment score of -3.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutBain Capital Specialty Finance.

Bain Capital Specialty Finance saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 822,500 shares, an increase of 20.4% from the April 15th total of 683,400 shares. Based on an average daily trading volume, of 384,900 shares, the short-interest ratio is presently 2.1 days. Approximately 1.6% of the shares of the company are short sold. View Bain Capital Specialty Finance's Current Options Chain.

Some companies that are related to Bain Capital Specialty Finance include Verra Mobility (VRRM), Immunovant (IMVT), GS ACQUISITION /SH CL A (GSAH), AdaptHealth (AHCO), HAYMAKER ACQUIS/SH CL A (HYAC), Grid Dynamics (GDYN), Alberton Acquisition (CFFA), Crescent Capital BDC (CCAP), Gores Holdings III (GRSH), FORUM MERGER II/SH CL A (FMCI), Global Cord Blood (CO), Thunder Bridge Acquisition II (SSPK), Leisure Acquisition (NEBU), Andina Acquisition Corp. III (AMCI) and Schultze Special Purpose Acquisition (ARYA). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), Honeywell International (HON), CVS Health (CVS), Home Depot (HD), Altria Group (MO), Pfizer (PFE), AT&T (T), Alibaba Group (BABA), Cisco Systems (CSCO) and Walt Disney (DIS).

(BCSF) raised $156 million in an initial public offering on Thursday, November 15th 2018. The company issued 7,500,000 shares at $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities served as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Bain Capital Specialty Finance's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Bain Capital Credit LP (16.84%), Employees Retirement System of Texas (7.96%), Dimension Capital Management LLC (7.26%), UBS Group AG (2.87%), HighTower Advisors LLC (1.06%) and Van ECK Associates Corp (0.83%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle and Thomas A Hough. View institutional ownership trends for Bain Capital Specialty Finance.

BCSF stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Dimension Capital Management LLC, Two Sigma Investments LP, Morgan Stanley, Glovista Investments LLC, Muzinich & Co. Inc., One Charles Private Wealth Services LLC, and Spark Investment Management LLC. View insider buying and selling activity for Bain Capital Specialty Finance.

BCSF stock was acquired by a variety of institutional investors in the last quarter, including Bain Capital Credit LP, Employees Retirement System of Texas, Sumitomo Mitsui Trust Holdings Inc., Two Sigma Advisers LP, IHT Wealth Management LLC, Radcliffe Capital Management L.P., First Trust Advisors LP, and Van ECK Associates Corp. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, and Thomas A Hough. View insider buying and selling activity for Bain Capital Specialty Finance.

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCSF stock can currently be purchased for approximately $11.20.

Bain Capital Specialty Finance has a market capitalization of $578.48 million and generates $197.95 million in revenue each year. The company earns $98.08 million in net income (profit) each year or $1.64 on an earnings per share basis.

The official website for Bain Capital Specialty Finance is www.baincapital.com.

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected]